Novel Prognostic Markers and Therapeutic Targets for Glioblastoma
Glioblastoma is the most common and lethal malignant brain tumor with a survival rate of 14.6 months and a tumor recurrence rate of ninety percent. Two key causes for glioblastomas grim outcome derive from the lack of applicable prognostic markers and effective therapeutic targets. By employing a lo...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Published: |
Virginia Tech
2016
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10919/71420 |